VIA Pharmaceuticals, Inc.
(NASDAQ:VIAP)|
0.170 0.000 (0.00%) Jan 08 - Close |
|
|
|
After-Hours 0.18 +0.01 (5.88%) Thu, 8 Jan 2009 7:40 PM
- Compare VIAP with:
- View: Line | Candlestick
Company Profile
VIA Pharmaceuticals, Inc.
750 Battery Street
San Francisco, CA 94111
United States - Map
Phone: (415) 283-2200
Fax: (415) 283-2201
Website: www.viapharmaceuticals.com
State of incorporation: Delaware
CEO: Dr. Lawrence K. Cohen, Ph.D.
Employees: 19
Sector: Healthcare
Industry Group: Drugs
Industry: Biotechnology
Dev gene therapy products
The Company is a development stage biotechnology company focused on the development of compounds for the treatment of cardiovascular disease.
Recent news for VIAP
-
VIA PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement
EDGAR Online - Dec 23 2008 at 3:32 ET
-
PR Newswire - Dec 23 2008 at 8:30 ET
-
VIA PHARMACEUTICALS, INC. Financials
EDGAR Online Financials - Nov 19 2008 at 9:04 ET
-
VIA PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition
EDGAR Online - Nov 12 2008 at 6:17 ET
-
VIA PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events
EDGAR Online - Nov 10 2008 at 6:09 ET
-
PR Newswire - Nov 09 2008 at 7:01 ET
-
PR Newswire - Nov 06 2008 at 8:30 ET
-
VIA Pharmaceuticals Announces Upcoming Investor Conference Presentations
PR Newswire - Nov 04 2008 at 8:30 ET